[House Prints 116-14]
[From the U.S. Government Publishing Office]


 


G:\CMTE\RU\16\RCP\RCP_H987.XML






                              MAY 8, 2019 
 
                  RULES COMMITTEE PRINT 116-14 
                  
           TEXT OF H.R. 987, STRENGTHENING HEALTH 
            CARE AND LOWERING PRESCRIPTION DRUG 
            COSTS ACT   
            
 
  [Showing the text of H.R. 938, H.R. 1499, H.R. 965, H.R. 1385, 
   H.R. 1386, H.R. 987, and H.R. 1010, as ordered reported by 
   the Committee on Energy and Commerce, with modifications.] 



1 SECTION 1. SHORT TITLE.

2      This Act may be cited as the ``Strengthening Health

3 Care and Lowering Prescription Drug Costs Act''.

4 SEC. 2. TABLE OF CONTENTS.

5      The table of contents of this Act is as follows:

  Sec. 1. Short title.

  Sec. 2. Table of contents.

          TITLE I--LOWERING PRESCRIPTION DRUG COSTS

     Subtitle A--Bringing Low-cost Options and Competition While Keeping 
                    Incentives for New Generics

  Sec. 101. Change conditions of first generic exclusivity to spur access and competition.

          Subtitle B--Protecting Consumer Access to Generic Drugs

  Sec. 111. Unlawful agreements.

  Sec. 112. Notice and certification of agreements.

  Sec. 113. Forfeiture of 180-day exclusivity period.

  Sec. 114. Commission litigation authority.

  Sec. 115. Statute of limitations.

     Subtitle C--Creating and Restoring Equal Access to Equivalent Samples

  Sec. 121. Actions for delays of generic drugs and biosimilar biological products.
 
  Sec. 122. REMS approval process for subsequent filers.
 
  Sec. 123. Rule of construction.

        TITLE II--HEALTH INSURANCE MARKET STABILIZATION


g:\VHLC\050719\050719.486.xml (726291|7)
May 7, 2019 (5:36 p.m.)




[TEXT NOT AVAILABLE]